|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 47/48 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1689846 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04793896.4 |
| Date of filing the European patent application | 2004-10-12 | |
| (97) | Date of publication of the European application | 2006-08-16 |
| (45) | Date of publication and mention of the grant of the patent | 2013-03-27 |
| (46) | Date of publication of the claims translation | 2013-06-25 |
| (86) | Number | PCT/US2004/030917 |
| Date | 2004-10-12 |
| (87) | Number | WO 2005/037992 |
| Date | 2005-04-28 |
| (30) | Number | Date | Country code |
| 509901 P | 2003-10-10 | US | |
| 960602 | 2004-10-08 | US |
| (72) |
STEEVES, Rita, US
LUTZ, Robert, US
CHARI, Ravi, US
XIE, Hongsheng, US
KOVTUN, Yelena, US
|
| (73) |
ImmunoGen, Inc.,
830 Winter Street, Waltham, MA 02451,
US
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Maitanzinoido DM1 konjugatai su antikūnu transtuzumabu, sujungti per neskylantį linkerį, ir jų panaudojimas navikams gydyti |
| Conjugates of maytansinoid DM1 with antibody trastuzumab, linked through a non-cleavable linker, and its use in the treatment of tumours |
| Payment date | Validity (years) | Amount | |
| 2023-09-19 | 347.00 EUR |